Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Other Non-Current Liabilities (2016 - 2026)

United Therapeutics' Other Non-Current Liabilities history spans 17 years, with the latest figure at $223.2 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 22.7% to $223.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $223.2 million, a 22.7% increase, with the full-year FY2025 number at $223.2 million, up 22.7% from a year prior.
  • Other Non-Current Liabilities hit $223.2 million in Q4 2025 for United Therapeutics, up from $214.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for UTHR hit a ceiling of $223.2 million in Q4 2025 and a floor of $67.4 million in Q3 2023.
  • Historically, Other Non-Current Liabilities has averaged $125.4 million across 5 years, with a median of $99.6 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 34.88% in 2023 and later skyrocketed 133.8% in 2024.
  • Tracing UTHR's Other Non-Current Liabilities over 5 years: stood at $104.8 million in 2021, then fell by 0.19% to $104.6 million in 2022, then dropped by 25.62% to $77.8 million in 2023, then skyrocketed by 133.8% to $181.9 million in 2024, then increased by 22.7% to $223.2 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for UTHR at $223.2 million in Q4 2025, $214.6 million in Q3 2025, and $207.3 million in Q2 2025.